Biological Age vs. Chronological Age: The Cardiovascular Tests That Tell the Truth

Two men. Same birthday. Let’s call them fifty-two.

One of them runs a company. Has for twelve years. Sleeps six hours when things are quiet, four when they are not. Exercises when the schedule allows, which is three weeks out of five. His last physical showed LDL of 112, blood pressure 128/82, fasting glucose 94. His doctor said everything looks good, see you in a year.

The other man sleeps seven hours, consistent. Runs four times a week. His LDL is 118. His blood pressure is 125/80. His last physical looked almost identical.

Here is what neither man knows. The first man’s coronary arteries contain calcified plaque at the 87th percentile for his age. His aortic pulse wave velocity, the measure of arterial stiffness, puts his vascular age at approximately 64. His VO2max is 31 ml/kg/min, which places him in the second-lowest quintile for men his age, associated with significantly elevated all-cause mortality.

The second man’s CAC score is 4. His VO2max is 44. His arterial stiffness profile is consistent with a 46-year-old.

Same birthday. Different bodies. And no standard annual physical would have distinguished them.

This is not a story about unusual medicine. This is a story about the gap between chronological age, which tells you how long you have existed, and biological age, which tells you the functional condition of the systems that will determine how much longer you last.

The distinction that your calendar cannot make

Chronological age is a calendar entry. It is useful for birthday parties and Social Security eligibility. It has almost no precision as a predictor of individual cardiovascular risk, because two people with the same birthday can have vascular systems that are twenty years apart in functional condition.

Biological age is not one number. It is a composite assessment of how your tissues are actually functioning, their oxidative burden, their inflammatory state, their structural integrity. For cardiovascular purposes, it is best approximated through a specific set of measurements, each of which captures a different dimension of the vascular and cardiorespiratory system.

The man who is reading this piece is, in all probability, someone who makes data-driven decisions. He runs financial models before a significant business decision. He reads the due diligence, not just the executive summary. He has never, in the history of his professional life, made a significant capital allocation based on a single metric that was not the most informative metric available.

He has almost certainly never measured his arterial age.

This is the gap. The same rigor he applies to his balance sheet has never been applied to his biology. The reasons are structural, the standard medical system does not routinely offer these measurements, but the gap is real, and it is consequential.

Proxy 1: Coronary artery calcium, the most concrete measure

The coronary artery calcium (CAC) score is a low-radiation CT scan that photographs calcified plaque in the walls of the coronary arteries. It is not a prediction. It is a current-state measurement. There is plaque there, or there is not. It is calcified, or it is not. The score quantifies how much. (A full clinical explanation of CAC scoring and what the result means)

The MESA (Multi-Ethnic Study of Atherosclerosis) investigators established the population distribution of CAC scores by age, sex, and ethnicity, giving every man who has the test a percentile score that compares his plaque burden to others of his exact demographic. (How to interpret your CAC score against age-matched peers) This percentile is the clearest available single-number measure of cardiovascular biological age: a 50-year-old man with a CAC score at the 90th percentile has more coronary calcification than 90% of 50-year-old men, his arteries have accumulated the plaque burden of someone substantially older. 5 / Solid

A CAC score of 0 in a man over 45 is genuinely reassuring. Event rates in men with a zero score are below 1% at ten years. A score between 1 and 100 indicates early atherosclerosis that warrants lifestyle and possibly pharmacological attention. A score above 400 indicates extensive plaque and belongs in a preventive cardiology practice immediately.

The cost is typically $75-150 out of pocket at a cardiac imaging center. It is not covered by all insurance plans for primary prevention. It is, by the information it provides per dollar spent, one of the highest-value tests a man over 45 can request.

Proxy 2: VO2 max, the fitness age with the strongest mortality data

VO2max, maximal oxygen consumption per kilogram of body weight per minute, is the measure of how effectively the cardiovascular and pulmonary systems deliver oxygen to working muscles. It is the functional readout of the entire cardiorespiratory chain: cardiac output, blood oxygen capacity, vascular delivery efficiency, and muscle oxidative metabolism.

It is also the single strongest predictor of all-cause mortality in the published literature.

The Mandsager et al. study, published in JAMA Network Open in 2018, examined the relationship between cardiorespiratory fitness and long-term mortality across 122,007 patients who underwent exercise treadmill testing. (Mandsager K et al., JAMA Netw Open 2018) The finding: moving from the lowest VO2max quintile to the second-lowest quintile was associated with approximately 50% reduction in all-cause mortality, a risk reduction larger than the benefit of quitting smoking, treating hypertension, or addressing elevated cholesterol. 5 / Solid The relationship was continuous: higher fitness was associated with lower mortality at every level of comparison.

VO2max declines at approximately 1% per year after age 25 in sedentary men, accelerating to 1.5-2% per year after age 45. This decline rate is not fixed. Men who maintain aerobic training reduce this decline to approximately 0.5% per year, preserving the cardiorespiratory fitness equivalent of someone fifteen to twenty years younger. The fitness age of a well-trained 52-year-old can be functionally equivalent to a sedentary 38-year-old by this measure. 4 / Promising

Laboratory VO2max testing uses a metabolic cart and an incremental exercise protocol to measure oxygen consumption directly. It is available at sports medicine facilities and some preventive cardiology centers. Consumer wearables (Garmin, Apple Watch) estimate VO2max through algorithms combining heart rate and pace data, correlating with lab measurements at approximately r=0.80-0.86, reasonable for tracking trends within a person over time, less reliable for absolute comparisons against published norms. The trend matters more than the number. A VO2max that has declined 8% over two years, with consistent training, is a cardiovascular signal worth investigating. (Exercise protocols that move VO2max and the evidence behind them)

Proxy 3: Pulse wave velocity, the arterial stiffness measure

Arteries are not passive pipes. They are elastic structures that expand under systolic pressure and recoil during diastole, generating a pressure wave that travels at a speed proportional to their stiffness. Stiffer arteries conduct the pressure wave faster. Pulse wave velocity (PWV) is the measurement of that speed.

The biological drivers of arterial stiffening are not chronological time. They are the cumulative load of blood pressure, advanced glycation end-products (the sticky cross-links that form between glucose and proteins in chronically elevated metabolic states), oxidized LDL particles lodging in the arterial wall, inflammatory cytokine accumulation, and collagen remodeling under sustained pressure. 5 / Solid A man who has carried hypertension, insulin resistance, elevated ApoB, and chronic stress load for fifteen years has accelerated the structural aging of his arteries regardless of his birth year.

A meta-analysis by Vlachopoulos et al., examining the relationship between aortic pulse wave velocity and cardiovascular events across 17 longitudinal studies and 15,877 subjects, found that each 1 m/s increase in aortic PWV was associated with a 14% increase in total cardiovascular events and a 15% increase in all-cause mortality, independent of age, blood pressure, and conventional cardiovascular risk factors. (Vlachopoulos C et al., JACC 2010) 5 / Solid Normal aortic PWV in men under 50 is below 8-9 m/s; values above 10 m/s indicate significant arterial aging.

PWV measurement is not yet a routine clinical test. It requires specialized equipment and is most available at vascular medicine centers and academic cardiology practices. It is, however, the most direct structural measure of vascular biological age, the arterial equivalent of reading a tree’s rings to determine its age rather than looking at the tag when it was planted.

Proxy 4: HRV and resting heart rate, the autonomic age window

Heart rate variability is the millisecond variation between consecutive heartbeats, reflecting the dynamic interplay of sympathetic and parasympathetic inputs to the cardiac conduction system. It is a window onto the autonomic nervous system, which in turn reflects the cumulative load that chronic stress, sleep disruption, inflammatory disease, and metabolic dysfunction have imposed on the cardiac regulatory architecture.

HRV declines with biological age, not chronological age. A 48-year-old man who has maintained consistent aerobic training, adequate sleep, and manageable chronic stress may have an HRV profile indistinguishable from a 34-year-old. A 38-year-old who has been under sustained sympathetic load for a decade, sleeping poorly, and carrying subclinical metabolic dysfunction may have the HRV profile of a 55-year-old. (What HRV measures, how to interpret the trend, and when a declining number demands clinical attention) 4 / Promising

Resting heart rate carries related information with stronger and longer-established evidence. A resting heart rate above 80 bpm, technically within the normal range, is associated with elevated cardiovascular mortality, independent of fitness level and conventional risk factors, across multiple large prospective cohorts. Men with resting heart rates above 90 bpm have hazard ratios for cardiovascular mortality roughly three times higher than those with resting heart rates below 50 bpm in some registry data. The trajectory matters as much as the absolute number: a resting heart rate that has risen 15 bpm over ten years of consistent exercise is not a fitness finding. It is an autonomic finding.

Proxy 5: The epigenetic clocks, real science, premature product

Steve Horvath’s DNA methylation age clock, described in Genome Biology in 2013, demonstrated that methylation patterns at 353 specific CpG sites across the genome predict biological age with remarkable accuracy across more than fifty tissue types. (Horvath S, Genome Biol 2013) 4 / Promising Subsequent generations of epigenetic clocks, PhenoAge, GrimAge, have improved on this foundation, with GrimAge in particular showing associations with all-cause mortality, physical functioning, and time-to-cancer.

This research is real. It is important. It represents a genuinely new approach to measuring biological age at the cellular level.

It has not yet translated into clinical action in a validated, reproducible way.

Consumer epigenetic testing services offer biological age calculations from blood samples. The underlying algorithms vary between companies, are often proprietary, and have not been independently validated for reproducibility. Two tests from two companies, from the same blood draw, can produce materially different age estimates. None of the consumer platforms have published peer-reviewed data on the clinical utility of their specific products for guiding preventive cardiovascular decisions.

This will change. The science is progressing fast enough that clinically validated epigenetic age testing may be routine within five to ten years. It is not there yet.

If you have $400 to spend on biological age information, spend it on a CAC score. If you have $600, add a VO2max test. Those two measurements give you validated, reproducible, outcomes-linked biological age data that will change your clinical picture in ways you can act on today.

The honest synthesis: there is no single number

There is no single clinically validated “biological age number” that accurately captures all dimensions of cardiovascular aging. What exists is a panel of age proxies, each measuring a different domain, each with different levels of evidence and clinical utility.

The honest hierarchy, for a man who wants to know where his cardiovascular system actually is:

Tier 1, Get these first: CAC score (direct arterial evidence, high clinical utility, accessible, inexpensive) and VO2max (strongest all-cause mortality predictor, measurable in a lab or approximated via wearable). These two measurements, taken together, give you more useful biological-age information than almost anything else available.

Tier 2, Add these when Tier 1 is done: ApoB (atherogenic particle burden, captures what LDL misses), fasting insulin (detects insulin resistance years before glucose becomes abnormal), and 24-hour ambulatory blood pressure (captures non-dipping and masked hypertension). (The test for insulin resistance and why it matters for vascular aging)

Tier 3, Useful for tracking, lower clinical action threshold: HRV trend from a wearable (autonomic window, longitudinal value), resting heart rate trend (autonomic and cardiovascular load marker).

Research context, not yet routine clinical: Epigenetic clock testing, pulse wave velocity (emerging clinical availability), full lipidomic panels.

This hierarchy is not about discouraging curiosity. It is about directing investment, of money, time, and attention, toward the tests that have the strongest evidence for changing clinical outcomes in the specific population of men over 40 who are trying to understand their cardiovascular biological age.

The system gap this reveals

There is a reason that most men over 45 have never had a CAC score, a VO2max test, or an ApoB measurement. The standard medical system does not offer them as routine primary prevention for men without established cardiovascular disease. The guidelines have been slow to incorporate these measures into standard panels, despite their strong evidence base. 5 / Solid

This is the System Gap that this pillar is named for. The gap between what the evidence supports and what the standard physical measures. The gap between the man’s intuition that something is off and the physician’s reassurance that everything looks fine. (The full account of what the annual physical misses in men over 40)

A man who has been told that his cholesterol is fine, his blood pressure is okay, and his physical looks good has received information. He has not received a biological age assessment. Those are not the same thing.

The man who understands this distinction, who knows the difference between a screening snapshot and a vascular age measurement, is the man who can walk into a clinical encounter and ask for what he actually needs. Asking your physician specifically: “What is my CAC score?” and “Can you refer me for a VO2max test?” and “What is my ApoB?” is not self-diagnosing. It is participating in your own care at the level of evidence that currently exists.

What the wearable data is and isn’t telling you

Most men in the relevant demographic are carrying a wearable that generates biological-age-adjacent data every day. The Whoop age estimate, the Garmin VO2max number, the Oura sleep score, the Apple Watch heart health notifications are all real-time biological signals.

They are not clinical-grade measurements. The VO2max estimate from a Garmin device correlates with laboratory testing at r=0.80-0.86 in active men, which is useful for tracking personal trends over months but can be off by 4-7 ml/kg/min in absolute terms, enough to misclassify a man’s fitness tier. The wearable HRV measurement (typically taken during sleep or immediately upon waking) correlates with gold-standard ECG-based measurement reasonably well for trend tracking, less well for absolute comparisons to clinical norms.

The correct use of wearable biological-age data is: use it for your own longitudinal trend. A VO2max that has been stable for three years and has dropped 15% in the last six months, with no change in training load, is a signal. A resting heart rate that has been 58 for two years and is now averaging 71, with no obvious explanation, is a signal. The wearable cannot tell you why the signal is there. It can tell you that the signal exists.

When the signal exists, the next step is a conversation with a physician who understands the evidence base for cardiovascular biological age testing, and who can order the measurements that turn the signal into a clinical picture.

The move: measuring what actually matters

TIMOKA, the one who does not flinch, is the man who gets the test and reads the result without turning away from it.

1. Schedule a CAC score. If you are between 40 and 65 and have never had one, this is the first step. Ask your physician to refer you, or book directly at a cardiac imaging center. The test takes fifteen minutes and costs roughly $75-150. The result will tell you more about your cardiovascular biological age than any other single measurement.

2. Measure your VO2max. A formal laboratory test is the most accurate option. An estimate from a Garmin or Apple Watch, taken over a consistent training period, is useful as a starting point for trend-tracking. If your estimated VO2max is below 35 ml/kg/min and you are under 55, that is a clinical finding worth discussing with a physician, not just a fitness metric.

3. Order an ApoB with your next lipid panel. Not instead of LDL, in addition to it. Ask specifically: “I’d like my ApoB included.” A normal LDL with an elevated ApoB in a man with metabolic syndrome or elevated triglycerides is a pattern the standard panel misses completely.

4. Ask about 24-hour blood pressure monitoring. If your clinic blood pressure is in the 125-135/80-85 range, the 24-hour monitor will determine whether that daytime reading is your baseline or your low point.

5. Take the cardiovascular risk assessment. It integrates your known numbers into a clinical risk picture and identifies which further measurements would most change that picture for your specific profile.

Your birth year is not your biology. Measuring the difference between the two is not longevity improvement. It is clinical accuracy.

Reviewed by Job Mogire, MD, FACP, FACC. Related reading: Coronary Artery Calcium Score | CAC Score by Age | HRV and Heart Rate Variability | Exercise and Heart Health | ApoB vs LDL | What Your Annual Physical Misses | Fasting Insulin Test | White Papers: CAC Score White Paper | HRV White Paper

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.